Danaher Corporation's results for Q3 2026 (quarter ended Sep 25, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-21. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $6,554 million (+8.3% vs a year earlier) |
| Diluted EPS (GAAP) | $1.71 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $2.11 |
| Full-year guidance | Raised |
Guidance
Danaher raised FY2026 adjusted EPS guidance to $8.57–8.62 from $8.45–8.60; expects Q4 core revenue growth of about 3.0%.
Why this label: Increasing FY2026 adjusted EPS guidance to $8.57-8.62 vs previous $8.45-8.60; core growth items have no prior or direction.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| adjusted diluted EPS (non-GAAP) | FY2026 | $8.57–8.62 | $8.45–8.60 |
| core sales growth (non-GAAP), total company | FY2026 | approximately +2.5% | not stated |
| core sales growth excluding respiratory testing (non-GAAP) | FY2026 | +mid-single digit | not stated |
Next-quarter outlook:
| Metric | Period | Range |
|---|---|---|
| core revenue growth excluding respiratory (non-GAAP) | Q4 2026 | +4.0% to +5.0% y/y |
| core revenue growth (non-GAAP) | Q4 2026 | approximately +3.0% y/y |
| adjusted operating profit margin (non-GAAP) | Q4 2026 | approximately 29.5% |
From the release
Revenue: "Sales · $ · 6,554 · $ · 6,053"
Earnings per share: "Net earnings were $1.2 billion, or $1.71 per diluted common share, up 34.5% year-over-year."
adjusted diluted EPS (non-GAAP): "For full year 2026, the Company is increasing its full year adjusted diluted net earnings per common share guidance to a range of $8.57 to $8.62 versus previous guidance of $8.45 to $8.60."
core sales growth (non-GAAP), total company: "Total Company · ~+3.0% · ~+2.5%"
core sales growth excluding respiratory testing (non-GAAP): "Core sales growth excluding respiratory testing (non-GAAP) · +4.0% - +5.0% · +Mid-single digit"
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Raised 2026 adjusted EPS guidance to $8.57–$8.62 from $8.45–$8.60.
Source
Danaher Corporation earnings release (SEC filing), accession 0000313616-26-000201, filed 2026-10-21.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.